Literature DB >> 18773053

Surgery for extrahepatic cholangiocarcinoma: predictors of survival.

J J Kloek1, F J Ten Kate, O R C Busch, D J Gouma, T M van Gulik.   

Abstract

The incidence of extrahepatic cholangiocarcinoma is increasing worldwide and is often in an advanced stage at diagnosis and difficult to treat. The TNM (tumor node metastasis) cancer staging system predicts survival on the basis of tumor histopathology and the presence of distant metastases. However, numerous prognostic factors have been described that are not included in the TNM system. This review focuses on the prognostic significance of clinical, surgical, and histopathological factors as reported in the literature. Overall, the most important independent prognostic factors for long-term survival are negative surgical margins, lymph node status, and differentiation grade of the tumor. Further improvement of staging systems and identification of prognostic factors are crucial if we are to better select patients for surgical and adjuvant therapy and, hence, increase the rate of curative resections.

Entities:  

Keywords:  Cholangiocarcinoma; lymph nodes; prognostic factors; resection margin; survival

Year:  2008        PMID: 18773053      PMCID: PMC2504374          DOI: 10.1080/13651820801992575

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  65 in total

1.  Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.

Authors:  Michael F Gerhards; Thomas M van Gulik; Dioniso González González; Erik A J Rauws; Dirk J Gouma
Journal:  World J Surg       Date:  2003-02       Impact factor: 3.352

2.  Preoperative evaluation with T-staging system for hilar cholangiocarcinoma.

Authors:  Ru-Fu Chen; Zhi-Hua Li; Jia-Jia Zhou; Jie Wang; Ji-Sheng Chen; Qing Lin; Qi-Bing Tang; Ning-Fu Peng; Zhi-Peng Jiang; Quan-Bo Zhou
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

3.  Improved survival in resected biliary malignancies.

Authors:  Attila Nakeeb; Khoi Q Tran; Michael J Black; Beth A Erickson; Paul S Ritch; Edward J Quebbeman; Stuart D Wilson; Michael J Demeure; William S Rilling; Kulwinder S Dua; Henry A Pitt
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

4.  Extended resections for hilar cholangiocarcinoma.

Authors:  P Neuhaus; S Jonas; W O Bechstein; R Lohmann; C Radke; N Kling; C Wex; H Lobeck; R Hintze
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

5.  Lymphatic spread differs according to tumor location in extrahepatic bile duct cancer.

Authors:  Takanori Yoshida; Toshifumi Matsumoto; Atsushi Sasaki; Yuji Morii; Kohei Shibata; Tetsuya Ishio; Seigo Kitano
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb

6.  Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; T Okaya; K Shinmura; N Nakajima
Journal:  J Am Coll Surg       Date:  1999-12       Impact factor: 6.113

7.  Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival.

Authors:  Lorenzo Capussotti; Andrea Muratore; Roberto Polastri; Alessandro Ferrero; Paolo Massucco
Journal:  J Am Coll Surg       Date:  2002-11       Impact factor: 6.113

Review 8.  Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

Authors:  T Kosuge; J Yamamoto; K Shimada; S Yamasaki; M Makuuchi
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

9.  Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.

Authors:  Sang Myung Woo; Ji Kon Ryu; Sang Hyub Lee; Ji Won Yoo; Joo Kyung Park; Yong-Tae Kim; Jin-Young Jang; Sun-Whe Kim; Gyeong Hoon Kang; Yong Bum Yoon
Journal:  Ann Surg Oncol       Date:  2007-08-19       Impact factor: 5.344

10.  Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.

Authors:  Yuichiro Tojima; Masato Nagino; Tomoki Ebata; Katsuhiko Uesaka; Junichi Kamiya; Yuji Nimura
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more
  9 in total

1.  Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.

Authors:  Kosin Wirasorn; Thundon Ngamprasertchai; Jarin Chindaprasirt; Aumkhae Sookprasert; Narong Khantikaew; Ake Pakkhem; Piti Ungarereevittaya
Journal:  World J Gastrointest Oncol       Date:  2013-04-15

2.  Outcome of surgical resection in Klatskin tumors.

Authors:  Alejandro Serrablo; Luis Tejedor
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

3.  Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.

Authors:  Hyeon Kang Koh; Hae Jin Park; Kyubo Kim; Eui Kyu Chie; Hye Sook Min; Sung W Ha
Journal:  Radiat Oncol J       Date:  2012-12-31

4.  Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma.

Authors:  Anthony T Ruys; Olivier R Busch; Erik A Rauws; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB Surg       Date:  2013-06-04

5.  Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients.

Authors:  Anthony T Ruys; Steven van Haelst; Olivier R Busch; Erik A Rauws; Dirk J Gouma; Thomas M van Gulik
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

6.  Definition of microscopic tumor clearance (r0) in pancreatic cancer resections.

Authors:  Anna Melissa Schlitter; Irene Esposito
Journal:  Cancers (Basel)       Date:  2010-11-25       Impact factor: 6.639

7.  Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.

Authors:  Daniel V T Catenacci; Christopher G Chapman; Peng Xu; Ann Koons; Vani J Konda; Uzma D Siddiqui; Irving Waxman
Journal:  Gastroenterology       Date:  2015-09-02       Impact factor: 22.682

8.  Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.

Authors:  Pyung Jung; Eung-Ho Cho; Sang-Bum Kim; Ryoung-Go Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-11-29

9.  The impact of portal vein resection on outcome of hilar cholangiocarcinoma.

Authors:  Ki Beom Kim; Dong Wook Choi; Jin Seok Heo; In Woong Han; Sang Hyun Shin; Yunghun You; Dae Joon Park
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.